Proliferative and secretory activity in human breast during natural and artificial menstrual cycles
- PMID: 3337211
- PMCID: PMC1880536
Proliferative and secretory activity in human breast during natural and artificial menstrual cycles
Abstract
Events of cell proliferation have been assessed by thymidine labeling index (TLI) in morphologically normal breast lobules from women of reproductive age. TLI is higher during the second half of the menstrual cycle both in women with natural menstrual cycles and in those with artificial cycles due to oral contraceptive (OC) use. TLI varies between 0.04% and 5.7% and declines with increasing age. There is no difference in mean TLI between OC users and nonusers if correction is made for the difference in age distribution between these two groups. Immunohistochemical detection of immunoglobulin A (IgA), secretory component (SC), and alpha-lactalbumin shows more frequent positive staining during artificial than natural menstrual cycles, and positive staining tends to be associated with higher TLI values. No significant variation in staining with cycle phase is detected in natural or artificial cycles. These results show that breast tissue does not resemble endometrium in the relationships that exist between proliferation, secretion, and menstrual cycle phase.
PIP: This study examines the relationships of mammary epithelial cell proliferation and secretory activity to the phase of the menstrual cycle in both natural menstrual cycles and those artificially regulated by oral contraceptives. Breast tissue was taken from 138 women with normal (26-30 day) menstrual cycles, hospitalized for biopsy or mastectomy. Date of last menstrual period was recorded and the tissue labeled with tritiated thymidine. Only morphologically normal lobules were used. Immunologic staining was done to reveal alpha-lactalbumin, alpha chains of immunoglobulin A, and secretory components. Since thymidine labeling index is known to decline with age, and hence with parity and oral contraceptive use, samples were standardized to age 30. In both natural and artificial cycles, maximum proliferation of mammary epithelium occurred in the latter half of the cycle. Immunoglobulin A and secretory component were detected more frequently during artificial menstrual cycle than during natural ones, and they tended to be associated with high thymidine labeling index values. The study confirms the predominance of proliferative events during the secretory phase of the cycle and the lack of any significant relationship between proliferation and secretion in the resting breast. The study also shows that the relationships between proliferation, secretion, and menstrual cycle phase exhibited by breast tissue are different from those exhibited by the endometrium.
Similar articles
-
Effect of combined oral contraceptives on breast epithelial proliferation in young women.Breast J. 2008 Sep-Oct;14(5):450-5. doi: 10.1111/j.1524-4741.2008.00621.x. Epub 2008 Jul 24. Breast J. 2008. PMID: 18657146 Clinical Trial.
-
Quantitative study of the lysosomes of epithelial cells from human mammary glands and fibroadenoma during proliferative and secretory phase of the menstrual cycle.Bull Assoc Anat (Nancy). 1994 Sep;78(242):19-21. Bull Assoc Anat (Nancy). 1994. PMID: 7833532
-
Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle.Breast Cancer Res. 2005;7(3):R306-13. doi: 10.1186/bcr994. Epub 2005 Feb 16. Breast Cancer Res. 2005. PMID: 15987425 Free PMC article.
-
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].Minerva Ginecol. 2007 Aug;59(4):415-25. Minerva Ginecol. 2007. PMID: 17923832 Review. Italian.
-
Proliferation of cultivated cells from normal, preneoplastic and neoplastic human breast tissue--preliminary report.Acta Histochem Suppl. 1990;39:181-7. Acta Histochem Suppl. 1990. PMID: 2080260 Review.
Cited by
-
Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.Horm Cancer. 2012 Dec;3(5-6):227-39. doi: 10.1007/s12672-012-0122-x. Epub 2012 Sep 12. Horm Cancer. 2012. PMID: 22968785 Free PMC article.
-
The endogenous progesterone metabolite, 5a-pregnane-3,20-dione, decreases cell-substrate attachment, adhesion plaques, vinculin expression, and polymerized F-actin in MCF-7 breast cancer cells.Endocrine. 2001 Oct;16(1):7-14. doi: 10.1385/endo:16:1:07. Endocrine. 2001. PMID: 11822829
-
Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.Breast Cancer Res Treat. 1996;37(3):217-28. doi: 10.1007/BF01806503. Breast Cancer Res Treat. 1996. PMID: 8825133
-
A, B, H, and Lewis-a and Lewis-b blood group antigens in human breast cancer: correlation with steroid hormone receptor and disease status.J Cancer Res Clin Oncol. 1993;119(8):486-92. doi: 10.1007/BF01215930. J Cancer Res Clin Oncol. 1993. PMID: 8509439 Free PMC article.
-
Apoptosis in the estrous and menstrual cycles.J Mammary Gland Biol Neoplasia. 1999 Apr;4(2):221-8. doi: 10.1023/a:1018737510695. J Mammary Gland Biol Neoplasia. 1999. PMID: 10426401 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous